卵巢疾病中的miRNAs:小但强大的造
Parsa Tafazoli1, Hanieh Motahari Rad2, Mehri Mashayekhi3
1Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Pathology, research and practice
|November 10, 2024
概括
微RNA (miRNA) 表达的变化与卵巢疾病有关,如早产卵巢衰竭 (POF) 和多囊性卵巢综合征 (PCOS). 了解这些miRNA变化为疾病诊断和治疗提供了潜在的机会.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生殖医学 生殖医学
背景情况:
- 微RNA (miRNA) 是一种调节基因表达的非编码RNA分子.
- 它们对于细胞分裂,分化和亡等生理过程至关重要.
- 失调的miRNA表达与各种病理有关,包括癌症和生殖障碍.
研究的目的:
- 分析早期卵巢衰竭 (POF),多囊性卵巢综合征 (PCOS) 和卵巢癌中的微RNA表达变化.
- 在这些卵巢条件下阐明miRNAs的分子机制和功能途径.
- 探索miRNAs作为用于诊断,治疗和预防策略的生物标志物的潜力.
主要方法:
- 对遗传数据库和现有文献进行系统审查.
- 鉴定与POF,PCOS和卵巢癌相关的基因.
- 对针对这些与疾病相关的基因的miRNAs的评估.
- 评估已识别的miRNAs的信号和功能途径.
主要成果:
- miRNAs显著调节正常的卵巢功能,包括卵泡生成和类固醇生成.
- 在POF,PCOS和卵巢癌中观察到改变的miRNA表达模式.
- 这些miRNAs对正常和病态细胞活动都表现出强大的调节作用.
结论:
- miRNAs在卵巢内的生理和病理细胞过程中起着至关重要的作用.
- 了解动态miRNA表达模式是开发诊断和治疗工具的关键.
- miRNA生物标志物有望促进卵巢疾病的管理.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:07Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
02:30siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
02:57piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:23RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K